'Government excessively controls drug prices, not recognising novel drugs' value'

Korea Biomedical Review

15 July 2022 - The Government is wielding excessive power to lower drug prices without recognising the values ​​of innovative medicines, an expert said.

Kim Sung-ju, an expert advisor for Lee & Ko's Healthcare Practice Group, published an article in the Korea Pharmaceutical and Bio-Pharma Manufacturers Association's policy report on Friday.

Read Korea Biomedical Review article

Michael Wonder

Posted by:

Michael Wonder